LINC02190

Across TCGA pan-cancer cohorts, LINC02190 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated LINC02190 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC02190 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02190 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LUSC show a favorable association.

MESO, HNSC, and READ are the cancer types where LINC02190 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.052	0.567	<.001	108	view →
HNSC	OS	Tertile	II,III,IV	0.082	0.711	<.001	72	view →
READ	OS	Tertile	II,III,IV	0.083	0.919	<.001	72	view →
ESCA	DFS	Tertile	III,IV	0.738	0.365	.014	36	view →
LIHC	OS	Tertile	II,III,IV	0.213	0.715	.020	36	view →
LUSC	DFS	Tertile	All	0.929	0.632	.023	21	view →
UCEC	DFS	Tertile	II,III,IV	0.606	0.828	.027	18	view →
SARC	DFS	Tertile	All	0.197	0.641	<.001	18	view →
ACC	DFS	Tertile	II,III,IV	0.242	0.724	.034	18	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

LINC02190–MESO (OS)

Open the MESO breakdown →